Sort
48,018 grants matching “immunotherapy”
Penn Center for AIDS Research
$3,512,603Ronald G Collman · University Of Pennsylvania · P30 · FY2019 · AI
Influenza and Emerging Infectious Diseases
$3,504,680Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,497,776Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy
$3,493,020Michael I Nishimura · Loyola University Chicago · P01 · FY2012 · CA
Transplant Tolerance in Non-Human Primates
$3,480,972Christian P Larsen · Emory University · U19 · FY2014 · AI
Transplant Tolerance in Non-Human Primates
$3,480,971Christian P Larsen · Emory University · U19 · FY2016 · AI
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
$3,478,888Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah · U01 · FY2025 · NS
The Therapy of CML
$3,477,908Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
$3,469,664Darell D Bigner · Duke University · P01 · FY2014 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,465,506Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$3,465,155Richard Childs · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,464,609Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Center for Human Immunology
$3,460,631Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
CANCER CENTER SUPPORT GRANT
$3,458,965University Of Colorado Denver · P30 · FY2003 · CA
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,457,326Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2020 · AI
Cancer Center Support Grant
$3,454,442Konstantin H. Dragnev · Dartmouth College · P30 · FY2025 · CA
Development of an Integrated Canine Data Commons (ICDC)
$3,450,938John Otridge · Leidos Biomedical Research, Inc. · N02 · FY2023 · CA
Childhood Cancer Data Initiative
$3,444,819Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
Childhood Cancer Survivorship Study
$3,444,307Gregory Armstrong · St. Jude Children'S Research Hospital · U24 · FY2025 · CA
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$3,443,414Robert E Donahue · National Heart, Lung, And Blood Institute · ZIC · FY2016 · HL
Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.
$3,440,662Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2022 · CA
The Therapy of CML
$3,438,273Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
THERAPY OF CML
$3,436,780University Of Texas Md Anderson Can Ctr · P01 · FY2004 · CA
TLE transcription cofactors in anti-viral and anti-tumor immunity
$3,436,588Hai-Hui Xue · Hackensack University Medical Center · R01 · FY2025 · AI
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$3,425,421Rachel R. Caspi · National Eye Institute · ZIA · FY2021 · EY